The death of Nigerian soprano Ifunanya Nwangene after a snakebite exposes gaps in healthcare access and Nigeria’s ongoing venomous snakebite crisis.
The tragic death of rising Nigerian soprano, Ifunanya Nwangene, after a snakebite has ignited a national conversation about the accessibility of healthcare and the persistent threat of venomous snakebites in Nigeria. The 26-year-old, known for her captivating performances on the local version of “The Voice,” succumbed to the bite last Saturday, highlighting systemic failures in the country’s response to a public health crisis that claims thousands of lives annually.
According to Ifunanya’s father, Christopher Nwangene, the incident unfolded swiftly. A snake entered their Abuja home and bit her on the wrist while she slept. Recognizing the urgency, Ifunanya immediately sought medical attention, aware that antivenom was her best chance of survival. However, her journey through the Nigerian healthcare system revealed a stark reality: a critical shortage of antivenom and, according to her family, a concerning lack of adequate care.
Initial reports indicate that Ifunanya initially applied a tourniquet, a practice now discouraged by medical professionals due to the risk of tissue damage and amputation. Upon arriving at Abuja’s Federal Medical Centre, Jabi, she discovered the hospital lacked the necessary antivenom. This prompted a desperate search, with Ifunanya’s father and friends scrambling to locate the life-saving medication at other facilities and pharmacies.
“They asked my brother to go and buy antivenom from a pharmacy,” Christopher Nwangene recounted, describing a frantic search that ultimately proved futile. While some antivenom was administered at the hospital, witnesses, including Ifunanya’s friend and choir director, Sam Ezugwu, claim it was insufficient. “While they were trying to stabilise her, she could not speak but she could make hand gestures. She was struggling to breathe,” Ezugwu stated.
The Federal Medical Centre, Jabi, has disputed these claims, asserting that antivenom was available and that their response was adequate. However, the Nwangene family remains unconvinced, questioning the decision to remove the tourniquet without having a viable alternative treatment readily available.
Ifunanya’s death is not an isolated incident. Nigeria bears the grim distinction of having the third-highest incidence of snakebites globally, with an estimated 20,000 cases recorded annually. The World Health Organization (WHO) recognizes venomous snakebites as a neglected tropical disease, contributing to approximately 30,000 deaths each year across sub-Saharan Africa.
The crisis is exacerbated by the high cost of polyvalent antivenom, ranging from 45,000 to 80,000 naira (approximately $33 to $58 USD) per vial and the challenges of maintaining the cold chain required for its storage, particularly in rural areas with unreliable electricity.
Stories of preventable deaths due to snakebites are tragically common. Shuaibu Mohammed shared his harrowing experience of surviving a cobra bite 15 years ago, thanks to timely access to antivenom. However, his sister, Sadiya, a mother of two, was not so fortunate. She died after being bitten in the night, as the nearest hospital lacked the necessary medication. Similarly, Hafiz Aminu narrowly escaped death after a cobra bite, relying on traditional herbal remedies when hospitals failed to provide antivenom.
While traditional remedies, such as those derived from the African custard apple, have shown some promise in laboratory studies, experts caution against their use, particularly in cases involving highly venomous snakes. The African Snakebite Institute emphasizes that these remedies are not reliably effective and can delay crucial medical intervention.
In response to Ifunanya’s death, the Nigerian Senate has called for increased efforts to ensure the nationwide availability of safe, effective, and affordable antivenom. However, the motion lacks a concrete timeline for implementation. Hopeful advancements are on the horizon, with scientists exploring the repurposing of blood thinners like heparin as a potential, low-cost antidote, potentially delivered via a device similar to an EpiPen.
Beyond logistical challenges, Christopher Nwangene believes a lack of empathy within the medical system contributed to his daughter’s demise. He remembers Ifunanya as a “very, very gentle girl” with an extraordinary talent for singing, a voice that brought joy to his life.
Her untimely death serves as a poignant reminder of the urgent need for systemic change and a renewed commitment to addressing the snakebite crisis in Nigeria, ensuring that no more lives are needlessly lost to this preventable tragedy. The incident also underscores the fact that snakebites are no longer a rural issue, as evidenced by the discovery of cobras in an upscale Abuja neighborhood.
Join our WhatsApp channel for daily updates
